LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.63 | 27.76 | 2226 | 4818 | 0.4620 | 0.8028 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.63 | 27.76 | 2544 | 4818 | 0.5280 | 0.8355 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.63 | 27.76 | 2595 | 4818 | 0.5386 | 0.8404 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.33 | 27.76 | 2303 | 5117 | 0.4501 | 0.7987 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.33 | 27.76 | 2352 | 5117 | 0.4596 | 0.8038 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.33 | 27.76 | 2665 | 5117 | 0.5208 | 0.8339 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.33 | 27.76 | 2718 | 5117 | 0.5312 | 0.8387 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.04 | 27.76 | 2438 | 5365 | 0.4544 | 0.8027 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.04 | 27.76 | 2492 | 5365 | 0.4644 | 0.8079 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.04 | 27.76 | 2747 | 5365 | 0.5120 | 0.8312 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.04 | 27.76 | 2820 | 5365 | 0.5256 | 0.8376 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.74 | 27.76 | 2542 | 5606 | 0.4534 | 0.8037 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.74 | 27.76 | 2590 | 5606 | 0.4620 | 0.8081 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.74 | 27.76 | 2844 | 5606 | 0.5073 | 0.8304 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.74 | 27.76 | 2912 | 5606 | 0.5194 | 0.8360 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.45 | 27.76 | 2685 | 5745 | 0.4673 | 0.8117 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.45 | 27.76 | 2744 | 5745 | 0.4776 | 0.8168 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.45 | 27.76 | 2908 | 5745 | 0.5061 | 0.8306 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.45 | 27.76 | 3035 | 5745 | 0.5283 | 0.8408 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.15 | 27.76 | 2802 | 5906 | 0.4744 | 0.8161 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.15 | 27.76 | 2857 | 5906 | 0.4837 | 0.8207 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.15 | 27.76 | 3034 | 5906 | 0.5137 | 0.8349 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.15 | 27.76 | 3136 | 5906 | 0.5309 | 0.8428 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 59.85 | 27.76 | 2932 | 6062 | 0.4836 | 0.8215 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 59.85 | 27.76 | 3001 | 6062 | 0.4950 | 0.8270 | MN20160318_Q01 | D10 |